FGFR2 and cancer: The proportions of FGFR2ΔE18, FGFR2amp and FGFR2hotspot varied across cancer entities, suggesting differential selections of FGFR2 aberrations and concurrent driver alterations among tissues of origin (Extended Data Fig. 10d).